Letters Section Editor: Robert M. Golub, MD, Senior Editor.
To the Editor: Atrial fibrillation (AF) is the most common arrhythmia leading to patient hospitalization.1,2 In their Clinical Review, Drs Vassallo and Trohman3 discuss the use of amiodarone for treatment of AF. They state that “because AFFIRM demonstrated no significant differences in stroke, quality of life, or mortality with rhythm vs rate control, physicians must consider the risk-benefit ratio of antiarrhythmic drugs to maintain sinus rhythm.”
Kapoor JR. Use of Amiodarone. JAMA. 2007;298(22):2617–2618. doi:10.1001/jama.298.22.2617-a
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.